vimarsana.com

Page 30 - அமெரிக்கன் சமூகம் ஆஃப் நெப்ராலஜி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

$10M artificial kidney prize now live via HHS, American Society of Nephrology

09:10 AM The KidneyX Artificial Kidney Prize, designed to accelerate the development of artificial kidneys toward human trials, is now open for submissions.   Leaders from Luminary Labs, the consultancy that designed and produced the prize, said it represents the ways that the government can promote innovation through public-private partnerships such as KidneyX, which is a collaboration between the U.S. Department of Health and Human Services and the American Society of Nephrology.   This is an absolute marathon and it is technologically possible, said Sara Holoubek, CEO and founder of Luminary Labs, in an interview with Healthcare IT News. What we needed was a mechanism to stimulate the market.  

Unhealthy Nebraska: Disparities threaten health status of non-White Nebraskans

When you first look at Nebraska’s high school graduation rates, the numbers seem commendable. Nearly 89% of Nebraska students graduated from high school within four years of starting ninth grade, according to 2018 statistics from the U.S. Department of Education. That was better than the national average of just over 85% and good for 12th in the nation. But then look at the racial and ethnic breakdown. White students in Nebraska graduated at a 92.5% rate. Hispanic students: about 81%. Black students: 78%. Native American students: 71%. The disparity between the rate for White students and that of the racial or ethnic group with the lowest rate — in Nebraska’s case, Native American students — puts Nebraska at 46th in the nation, according to the 2020 edition of America’s Health Rankings, which are compiled by the United Healthcare Foundation.

Largest Kidney Group Thanks President Trump For Signing Pandemic Relief And Transplant Drug Coverage

Largest Kidney Group Thanks President Trump For Signing Pandemic Relief And Transplant Drug Coverage Transplant Drug Reform A Milestone in First Year of AAKP s Decade of the Kidney™ News provided by Share this article Share this article WASHINGTON, Dec. 27, 2020 /PRNewswire/ The American Association of Kidney Patients (AAKP), the largest and oldest kidney patient organization in the United States, released the following statement upon President Donald J. Trump s signing of bipartisan, Congressionally authorized immunosuppressive drug coverage provisions for kidney transplant patients. The provisions were included in Congressional actions related to the COVID-19 pandemic relief package and $1.4 trillion omnibus spending bill. AAKP patient volunteers used the organization s sophisticated communications systems to drive Congressional action and mobilize the most comprehensive national grassroots campaign in its 50-year history, the effort included, coordinated local virtual kid

Is It Time For A Race Reckoning In Kidney Medicine?

Some in the medical community now question the use of race in kidney care. They argue it could exacerbate health disparities. As the U.S. grapples with the effects of systemic racism, some in the medical community are questioning whether the tools they use to assess patient health may be contributing to racial health disparities. That debate is playing out most prominently in the world of kidney medicine. Black people are almost four times more likely to suffer from kidney failure than non-Hispanic whites. And once they get to that stage, Black patients spend months longer waiting for a kidney transplant than white patients.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.